Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 15.30% is 274% above its 5-year average of -8.81%, near the high end of its 5-year range (-45.10%–15.30%).
As of the fiscal period ended Tuesday, March 31, 2026. 4217.79% above its 12-month average of 0.35%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
15.30%
EBITDA MARGIN AVG TTM
0.35%
EBITDA MARGIN AVG 3Y
-0.81%
EBITDA MARGIN AVG 5Y
-6.54%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+4217.79%
CURRENT VS 3Y AVG
+1993.31%
CURRENT VS 5Y AVG
+333.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Oscar Health, Inc.
Market Cap
$7.81B
EBITDA Margin
15.30%
TTM Avg
0.35%
3Y Avg
-0.81%
5Y Avg
-6.54%
Market Cap
$8.18B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
Market Cap
$7.06B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$9.36B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
Market Cap
$10.19B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
Market Cap
$10.37B
EBITDA Margin
-7.87%
TTM Avg
-5.60%
3Y Avg
-1.35%
5Y Avg
0.44%
Market Cap
$10.39B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $7.81B | 15.30% | 0.35% | -0.81% | -6.54% |
| Tempus AI, Inc. (TEM)vs › | $8.18B | -11.84% | -53.07% | -52.51% | -64.32% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 6.82% | 6.08% | -0.44% | -8.67% |
| Insulet Corp. (PODD)vs › | $9.23B | 21.67% | 20.24% | 16.36% | 15.66% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.36B | 18.42% | 17.41% | 19.12% | 20.05% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 2.15% | 3.41% | 4.20% | 4.49% |
| Henry Schein, Inc. (HSIC)vs › | $10.21B | 8.11% | 8.11% | 8.28% | 8.19% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.87% | -5.60% | -1.35% | 0.44% |
| Universal Health Services, Inc. (UHS)vs › | $10.39B | 15.05% | 14.69% | 13.35% | 14.10% |
| Bio-Techne Corporation (TECH)vs › | $11.27B | 17.40% | 22.43% | 29.14% | 30.66% |
Gross Margin
17.4%
EBITDA Margin
15.3%
Operating Margin
0.1%
Net Margin
-0.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 15.30% |
| 2025-12-31 | -11.62% |
| 2025-09-30 | -4.08% |
| 2025-06-30 | -7.80% |
| 2025-03-31 | 9.97% |
| 2024-12-31 | -5.79% |
| 2024-09-30 | -1.85% |
| 2024-06-30 | 3.09% |
| 2024-03-31 | 8.69% |
| 2023-12-31 | -9.98% |
| 2023-09-30 | -3.86% |
| 2023-06-30 | -0.36% |
| 2023-03-31 | -2.22% |
| 2022-12-31 | -21.54% |
| 2022-09-30 | -18.76% |
| 2022-06-30 | -10.22% |
| 2022-03-31 | -7.12% |
| 2021-12-31 | -37.36% |
| 2021-09-30 | -45.10% |
| 2021-06-30 | -12.58% |
| 2021-03-31 | -21.74% |
| 2020-12-31 | -99.69% |
| 2020-09-30 | -57.91% |
| 2020-06-30 | -25.30% |
| 2020-03-31 | -75.86% |
